ENTITY

Grace Therapeutics (GRCE US)

3
Analysis
Health CareUnited States
Grace Therapeutics, Inc. operates as a late-stage biopharma company. The Company focuses on drug delivery and technologies addressing rare and orphan diseases. Grace Therapeutics serves clients in Canada and the United States.
more
18 Nov 2024 23:00Issuer-paid

GRCE: FY:25 Second Quarter Results

Grace is a clinical-stage, biotechnology company focused on rare disease. Its lead program, GTX-104, is a novel injectable formulation of...

Share
05 Nov 2024 11:22Issuer-paid

Grace Therapeutics, Inc: Initiating Coverage – From Confusion to Infusion

Grace is a clinical-stage, biotechnology company focused on rare disease.Its lead program is for GTX-104, a novel injectable formulation of...

Share
10 Oct 2024 10:55Syndicated

Acasti Pharma Inc (ACST) - Wednesday, Jul 10, 2024

Acasti Pharma is making progress in developing IV nimodipine for acute subarachnoid hemorrhages. Lead asset GTX-104 is the primary focus of their...

Logo
139 Views
Share
No more insights
x